Perspective Therapeutics, Inc. — Director's Dealing 2019

Jun 24, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2019-06-18

Reporting Person: Austin Mark John (Controller/Prin Fin&Acct Offic)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-18	Stock Options (right to buy)	$0.43	A	50000	Acquired	2029-06-18	Common Stock (50000)	Direct

Footnotes

F1: 25% vested as of 6/18/2019, and the remaining 75% will vest over the next three (3) years, commencing on 6/18/2020, until fully vested.